(NYSE: LLY) ELI LILLY &'s forecast annual revenue growth rate of 8.46% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.82%.
ELI LILLY &'s revenue in 2020 is $23,213,800,000.On average, 3 Wall Street analysts forecast LLY's revenue for 2021 to be $26,259,230,272,822, with the lowest LLY revenue forecast at $26,069,393,859,269, and the highest LLY revenue forecast at $26,409,103,441,292. On average, 3 Wall Street analysts forecast LLY's revenue for 2022 to be $26,887,239,154,373, with the lowest LLY revenue forecast at $26,792,648,060,464, and the highest LLY revenue forecast at $27,036,595,828,843.
In 2023, LLY is forecast to generate $28,816,539,367,616 in revenue, with the lowest revenue forecast at $28,816,539,367,616 and the highest revenue forecast at $28,816,539,367,616.